You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Thymmune Therapeutics, Inc. (Add-on Acquistion, in 2026)

Transaction #139019
Investor
1
Sign up to view
Target Company
Thymmune Therapeutics, Inc.
Life Science · United States
Sellers
No seller data
02 Jul 2026
Announced
Target Company
Company Sector Entity Type Status State Country
Thymmune Therapeutics, Inc. Life Science Private Active Massachusetts (MA) United States
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers
Seller
View Sellers
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Thymmune Therapeutics, Inc. acquisition deal?
This transaction is an acquisition of Thymmune Therapeutics, Inc. (Add-on Acquistion) in 2026. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Thymmune Therapeutics, Inc. acquisition happen?
This transaction was announced on 02 Jul 2026.
What is the deal value of the Thymmune Therapeutics, Inc. acquisition?
Deal value information for this transaction is available on AcquityData.
Who are the investors in the Thymmune Therapeutics, Inc. transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Thymmune Therapeutics, Inc. deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial